| Primary |
| Drug Use For Unknown Indication |
22.4% |
| Cellulitis |
14.7% |
| Urinary Tract Infection |
7.8% |
| Localised Infection |
6.0% |
| Infection |
5.2% |
| Product Used For Unknown Indication |
5.2% |
| Streptococcal Infection |
5.2% |
| Kidney Infection |
4.3% |
| Medical Diet |
4.3% |
| Otitis Media |
3.4% |
| Antibiotic Prophylaxis |
2.6% |
| Cyst |
2.6% |
| Dermatitis Allergic |
2.6% |
| Mastitis |
2.6% |
| Sinusitis |
2.6% |
| Bronchitis |
1.7% |
| Diabetes Mellitus |
1.7% |
| Ingrowing Nail |
1.7% |
| Lymphadenitis |
1.7% |
| Lymphadenopathy |
1.7% |
|
| Vomiting |
13.0% |
| Anaphylactic Reaction |
10.4% |
| Rash |
10.4% |
| Stevens-johnson Syndrome |
7.8% |
| Medication Error |
6.5% |
| Urticaria |
6.5% |
| Swelling Face |
5.2% |
| Anaphylactic Shock |
3.9% |
| Rash Papular |
3.9% |
| Stomach Discomfort |
3.9% |
| Suicide Attempt |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Clostridium Difficile Colitis |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Dyspnoea |
2.6% |
| Foetal Movements Decreased |
2.6% |
| Headache |
2.6% |
| Hypersensitivity |
2.6% |
| Infection |
2.6% |
| Pneumonia |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.6% |
| Product Used For Unknown Indication |
23.6% |
| Pain |
4.4% |
| Neuropathy Peripheral |
4.3% |
| Diabetes Mellitus |
4.1% |
| Depression |
3.9% |
| Hypertension |
3.7% |
| Bronchitis |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Sinusitis |
2.7% |
| Antibiotic Therapy |
2.6% |
| Ill-defined Disorder |
2.2% |
| Cellulitis |
2.1% |
| Crohn's Disease |
2.0% |
| Infection |
1.8% |
| Urinary Tract Infection |
1.8% |
| Smoking Cessation Therapy |
1.5% |
| Blood Cholesterol Increased |
1.3% |
| General Anaesthesia |
1.2% |
| Back Pain |
1.1% |
|
| Drug Hypersensitivity |
52.4% |
| Rash |
4.0% |
| Vomiting |
4.0% |
| Mood Altered |
3.6% |
| Urticaria |
3.6% |
| Weight Decreased |
3.2% |
| Drug Ineffective |
2.8% |
| Postoperative Infection |
2.8% |
| Hyponatraemia |
2.4% |
| Respiratory Failure |
2.4% |
| Urinary Tract Infection |
2.4% |
| Urine Phosphate Increased |
2.4% |
| Hypersensitivity |
2.0% |
| No Adverse Event |
2.0% |
| Weight Increased |
2.0% |
| Diarrhoea |
1.6% |
| International Normalised Ratio Increased |
1.6% |
| Nausea |
1.6% |
| Poor Quality Drug Administered |
1.6% |
| Pruritus Generalised |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
18.3% |
| Pain |
8.1% |
| Hypertension |
4.0% |
| Depression |
3.8% |
| Multiple Myeloma |
3.7% |
| Crohn's Disease |
3.6% |
| Acne |
3.5% |
| Breast Cancer |
2.8% |
| Metastases To Bone |
2.6% |
| Contraception |
2.5% |
| Anxiety |
2.4% |
| Osteoporosis |
2.4% |
| Prophylaxis |
2.3% |
| Rheumatoid Arthritis |
2.0% |
| Breast Cancer Metastatic |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Nausea |
1.9% |
| Asthma |
1.8% |
| Urinary Tract Infection |
1.8% |
|
| Weight Decreased |
14.6% |
| Vomiting |
9.8% |
| Pulmonary Embolism |
7.0% |
| Urinary Tract Infection |
6.3% |
| Weight Increased |
6.0% |
| Pain |
5.8% |
| Vision Blurred |
5.2% |
| Wound Infection Staphylococcal |
5.0% |
| Deep Vein Thrombosis |
4.9% |
| Ventricular Septal Defect |
4.0% |
| Thrombophlebitis Superficial |
3.8% |
| Wound Dehiscence |
3.6% |
| Injury |
3.5% |
| Syncope |
3.4% |
| Type 2 Diabetes Mellitus |
3.2% |
| Rash |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Wheezing |
2.7% |
| Anxiety |
2.5% |
| Dyspnoea |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
64.3% |
| Gastrooesophageal Reflux Disease |
5.7% |
| Infection |
4.3% |
| Anxiety |
2.9% |
| Furuncle |
2.9% |
| Lung Neoplasm Malignant |
2.9% |
| Analgesic Therapy |
1.4% |
| Back Pain |
1.4% |
| Bipolar Disorder |
1.4% |
| Dysmenorrhoea |
1.4% |
| Influenza |
1.4% |
| Liver Transplant |
1.4% |
| Nasopharyngitis |
1.4% |
| Neuropathy Peripheral |
1.4% |
| Sleep Disorder |
1.4% |
| Smoking Cessation Therapy |
1.4% |
| Tooth Infection |
1.4% |
| Torticollis |
1.4% |
|
| Drug Interaction |
28.6% |
| Urinary Tract Infection |
21.4% |
| Adverse Drug Reaction |
7.1% |
| Agranulocytosis |
7.1% |
| Dyspepsia |
7.1% |
| Performance Status Decreased |
7.1% |
| Therapeutic Response Decreased |
7.1% |
| Type 2 Diabetes Mellitus |
7.1% |
| Vertigo |
7.1% |
|
